These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3118345)

  • 1. Imipenem: the first thienamycin antibiotic.
    Williams RJ
    Postgrad Med J; 1986; 62 Suppl 2():75-7. PubMed ID: 3118345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of imipenem: the first thienamycin antibiotic.
    Kropp H; Gerckens L; Sundelof JG; Kahan FM
    Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.
    Tischhauser G; Kayser FH
    Infection; 1983; 11(4):219-26. PubMed ID: 6578202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Cristiano P; Abbate GF; Alagia I; Leonessa V; Giaquinto E; Savioli L
    Drugs Exp Clin Res; 1985; 11(1):39-48. PubMed ID: 3869802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P; Naas T; Fortineau N; Poirel L
    Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selection of resistant variants by broad spectrum beta-lactam antibiotics: to what extent is there cross resistance between imipenem and other beta-lactam antibiotics?].
    Kahan F; Kropp H
    Immun Infekt; 1986 Nov; 14(6):232-5. PubMed ID: 3100429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of resistance in imipenem therapy in Pseudomonas aeruginosa].
    Krech T; Naumann P
    Immun Infekt; 1986 Nov; 14(6):224-6. PubMed ID: 3100426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity of bacteria to antibiotics in urinary tract infection].
    Mróz E; Gościniak G; Ruczkowska J; Grzybek-hryncewicz K; Choroszy I
    Wiad Lek; 1981 Jul; 34(13):1085-9. PubMed ID: 6795830
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM; Keeley JM
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HR 810 (cefpirome). Experimental evaluation of the in vitro and in vivo antibiotic activity of a new amino-2-thiazole methoxy- imino cephalosporin].
    Chantot JF; Bryskier A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):482-6. PubMed ID: 3937124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem: morphological changes and lethal effects on Pseudomonas aeruginosa.
    Carlone NA; Ferrero M; Cuffini AM; Cavallo R
    Drugs Exp Clin Res; 1987; 13(10):623-9. PubMed ID: 3123190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of bacterial endocarditis].
    Halawa B
    Wiad Lek; 1982 Nov; 35(19-20):1257-64. PubMed ID: 6819721
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
    Lami JL; Wilson SE; Hopkins JA
    Am Surg; 1991 Dec; 57(12):769-74. PubMed ID: 1746792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.